Germany's Struggle with Prices for Patent-protected Drugs
Kifmann, Mathias, Neelsen, Sven
core
Generating evidence that meets the requirements of both regulatory agencies and HTA bodies. [PDF]
Wieseler B, Preukschat D, Kranz P.
europepmc +1 more source
Herzinsuffizienz – IQWiG legt vorläufige Ergebnisse vor [PDF]
openaire +1 more source
Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs. [PDF]
Kranz P, McGauran N, Ünal C, Kaiser T.
europepmc +1 more source
Gutachten zur zukünftigen medizintechnischen Entwicklung für die somatische Akutversorgung : Literatur-Review und Expertenbefragung zu erwarteten Leistungsmengen im Rahmen der stationären Spitalplanung der Kantone Bern und Zürich [PDF]
Brügger, Urs +2 more
core +1 more source
IQWiG bestätigt beträchtlichen Zusatznutzen für Edoxaban [PDF]
openaire +1 more source
Navigating change: a comparative analysis of health technology assessment reforms across agencies - processes, drivers, and interdependencies. [PDF]
Kumar G +10 more
europepmc +1 more source
Weaning From Tobacco with Nicotine or Varenicline in Severe and Mild Tobacco Dependence—Findings of a Meta-Analysis. [PDF]
Selbach C +6 more
europepmc +1 more source
Systemic Psychotherapy: An Introduction to Its Theoretical Foundations and Clinical Practice. [PDF]
von Sydow K, Beher S, Retzlaff R.
europepmc +1 more source

